BCMA

Ongoing clinical trials and approved products targeting BCMA, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.

0ongoing therapy trials
2ongoing imaging trials
0approved products

Target note

Full name
B-cell maturation antigen (BCMA)
Nature
Plasma cell receptor, target of myeloma CAR-T cells and bispecifics.
Normal expression
Plasma cells.
Value
Assessing expression before anti-BCMA treatment.
Approaches
Antibodies and fragments labeled with ⁶⁸Ga or ⁸⁹Zr.
Indications explored
Multiple myeloma (research).
Points of caution
Early stage.

Ongoing imaging trials · 2Open in the radar →

TrialPhaseStatusSponsorCountries
BCMA tracerNCT07319897 · MyelomaPhase 3RecruitingPeking University First Hospital1
BCMA tracerNCT07353554 · MyelomaNo phaseNot yet recruitingPeking Union Medical College Hospital1

Cite this page

BCMA. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/bcma/ (accessed [date]).

A monitoring tool with no regulatory value: check every item at its source.